© 2021 by the authors.Pancreatic cancer is one of the most lethal malignancies with a poor and gloomy prognosis and the highest mortality-to-incidence ratio. Pancreatic cancer remains an incurable malignancy, and current therapies are ineffective. We isolated cancer stem cells (CSCs) from the human PANC-1 pancreatic cancer cell line as CD44+CD24+EpCAM+ cells. These CSCs form pancreatic cancer spheres or spheroids and develop tumors in SCID mice after subcutaneous injection of as few as 100 cells per mouse. Here, we found that the alkylphospholipid analog edelfosine inhibited CSC pancreatic cancer spheroid formation and induced cell death, as assessed by an increase in the percentage of cells in the sub-G0/G1 region by means of flow cytometr...
Pancreatic cancer (PC) begins within the organ of the pancreas, which produces digestive enzymes, an...
Despite significant efforts to improve pancreatic ductal adenocarcinoma (PDAC) clinical outcomes, ov...
This article belongs to the Special Issue Latest Development in Pancreatic Cancer.Pancreatic ductal ...
Pancreatic cancer is one of the most lethal malignancies with a poor and gloomy prognosis and the hi...
32 p.-11 fig.Pancreatic ductal adenocarcinoma (PDAC), the most common malignancy of the pancreas, sh...
Pancreatic ductal adenocarcinoma (PDAC), the most common malignancy of the pancreas, shows a dismal ...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
Pancreatic cancer is a devastating disease with a current overall 5-year survival rate of only 10%, ...
Pancreatic cancer is a devastating disease with a dismal prognosis and poor treatment outcomes. Sear...
The so-called alkylphospholipid analogs (APLs) constitute a family of synthetic antitumor compounds ...
Background. Chemoresistance is an important clin-ical problem in pancreatic cancer. As the mitogen-a...
ABSTRACT Pancreatic ductal adenocarcinoma is refractory to available therapies. We have previously s...
Pancreatic cancer is one of the most lethal diseases, which has 5-year survival rate of under 8% and...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of tumours, and its incidenc...
Pancreatic adenocarcinoma (PDAC) is one of the most aggressive and devastating human malignancies wi...
Pancreatic cancer (PC) begins within the organ of the pancreas, which produces digestive enzymes, an...
Despite significant efforts to improve pancreatic ductal adenocarcinoma (PDAC) clinical outcomes, ov...
This article belongs to the Special Issue Latest Development in Pancreatic Cancer.Pancreatic ductal ...
Pancreatic cancer is one of the most lethal malignancies with a poor and gloomy prognosis and the hi...
32 p.-11 fig.Pancreatic ductal adenocarcinoma (PDAC), the most common malignancy of the pancreas, sh...
Pancreatic ductal adenocarcinoma (PDAC), the most common malignancy of the pancreas, shows a dismal ...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
Pancreatic cancer is a devastating disease with a current overall 5-year survival rate of only 10%, ...
Pancreatic cancer is a devastating disease with a dismal prognosis and poor treatment outcomes. Sear...
The so-called alkylphospholipid analogs (APLs) constitute a family of synthetic antitumor compounds ...
Background. Chemoresistance is an important clin-ical problem in pancreatic cancer. As the mitogen-a...
ABSTRACT Pancreatic ductal adenocarcinoma is refractory to available therapies. We have previously s...
Pancreatic cancer is one of the most lethal diseases, which has 5-year survival rate of under 8% and...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of tumours, and its incidenc...
Pancreatic adenocarcinoma (PDAC) is one of the most aggressive and devastating human malignancies wi...
Pancreatic cancer (PC) begins within the organ of the pancreas, which produces digestive enzymes, an...
Despite significant efforts to improve pancreatic ductal adenocarcinoma (PDAC) clinical outcomes, ov...
This article belongs to the Special Issue Latest Development in Pancreatic Cancer.Pancreatic ductal ...